These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17577007)

  • 1. Ethical issues in stopping randomized trials early because of apparent benefit.
    Mueller PS; Montori VM; Bassler D; Koenig BA; Guyatt GH
    Ann Intern Med; 2007 Jun; 146(12):878-81. PubMed ID: 17577007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early stopping of randomized clinical trials for overt efficacy is problematic.
    Bassler D; Montori VM; Briel M; Glasziou P; Guyatt G
    J Clin Epidemiol; 2008 Mar; 61(3):241-6. PubMed ID: 18226746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
    Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
    Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thinking clearly about the FIRST trial: addressing ethical challenges in cluster randomised trials of policy interventions involving health providers.
    Horn AR; Weijer C; Hey SP; Brehaut J; Fergusson DA; Goldstein CE; Grimshaw J; Taljaard M
    J Med Ethics; 2018 Sep; 44(9):593-598. PubMed ID: 29703860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials.
    McKenzie JE; Herbison GP; Roth P; Paul C
    Trials; 2010 Mar; 11():28. PubMed ID: 20302671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed consent in cluster randomised trials: new and common ethical challenges.
    Lignou S
    J Med Ethics; 2018 Feb; 44(2):114-120. PubMed ID: 28780528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping at nothing? Some dilemmas of data monitoring in clinical trials.
    Goodman SN
    Ann Intern Med; 2007 Jun; 146(12):882-7. PubMed ID: 17577008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 1: Ethical considerations.
    Ball G; Piller LB; Silverman MH
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S2-4. PubMed ID: 21664987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster-randomized trials: A closer look.
    McRae AD; Taljaard M; Weijer C
    Clin Trials; 2016 Jun; 13(3):294-300. PubMed ID: 26931364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are distinctive ethical principles required for cluster randomized controlled trials?
    Hutton JL
    Stat Med; 2001 Feb; 20(3):473-88. PubMed ID: 11180314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled trials as minimal risk: an ethical analysis.
    Morris MC; Nelson RM
    Crit Care Med; 2007 Mar; 35(3):940-4. PubMed ID: 17255879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical considerations in industry-sponsored multiregional clinical trials.
    Ibia E; Binkowitz B; Saillot JL; Talerico S; Koerner C; Ferreira I; Agarwal A; Metz C; Maman M
    Pharm Stat; 2010; 9(3):230-41. PubMed ID: 20824884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
    Briel M; Lane M; Montori VM; Bassler D; Glasziou P; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Culebro CR; da Silva SA; Flynn DN; Elamin MB; Strahm B; Murad MH; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Abu Elnour NO; You JJ; Karanicolas PJ; Bucher HC; Lampropulos JF; Nordmann AJ; Burns KE; Mulla SM; Raatz H; Sood A; Kaur J; Bankhead CR; Mullan RJ; Nerenberg KA; Vandvik PO; Coto-Yglesias F; Schünemann H; Tuche F; Chrispim PP; Cook DJ; Lutz K; Ribic CM; Vale N; Erwin PJ; Perera R; Zhou Q; Heels-Ansdell D; Ramsay T; Walter SD; Guyatt GH
    Trials; 2009 Jul; 10():49. PubMed ID: 19580665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Members of research ethics committees accepted a modification of the randomized consent design.
    Schellings R; Kessels AG; Ter Riet G; Kleijnen J; Leffers P; Knottnerus JA; Sturmans F
    J Clin Epidemiol; 2005 Jun; 58(6):589-94. PubMed ID: 15878472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
    Saxman SB
    Bioethics; 2015 Feb; 29(2):59-65. PubMed ID: 24547903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early stopping of clinical trials: charting the ethical terrain.
    Malmqvist E; Juth N; Lynöe N; Helgesson G
    Kennedy Inst Ethics J; 2011 Mar; 21(1):51-78. PubMed ID: 21598846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive trials in clinical research: scientific and ethical issues to consider.
    van der Graaf R; Roes KC; van Delden JJ
    JAMA; 2012 Jun; 307(22):2379-80. PubMed ID: 22692169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.